Householder Group Estate & Retirement Specialist’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,500
Closed -$22K 634
2024
Q3
$22K Hold
1,500
0.01% 664
2024
Q2
$7K Hold
1,500
﹤0.01% 877
2024
Q1
$10.2K Hold
1,500
﹤0.01% 811
2023
Q4
$7K Hold
1,500
﹤0.01% 833
2023
Q3
$5.13K Buy
+1,500
New +$8.43K ﹤0.01% 937
2023
Q1
$3K Buy
+700
New +$3.01K ﹤0.01% 1021

Other funds holding CAPR

Householder Group Estate & Retirement Specialist's CAPR Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist sold out of Capricor Therapeutics (CAPR) in Q4 2024, closing a stake of 1,500 shares — an estimated $22K sold.

Householder Group Estate & Retirement Specialist first reported a position in CAPR in Q1 2023 and held it in 6 quarters. The position peaked at $22K in Q3 2024. 108 funds tracked by Wall St. Rank hold CAPR as of Q4 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining Capricor Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 1,500 Capricor Therapeutics shares in Q4 2024, an estimated $22K.
  • Householder Group Estate & Retirement Specialist first reported a position in Capricor Therapeutics in Q1 2023 and held it in 6 quarters.
  • Householder Group Estate & Retirement Specialist's Capricor Therapeutics position peaked at $22K in Q3 2024.
  • 108 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.